Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by justintime1990on Apr 01, 2021 6:26pm
157 Views
Post# 32925441

RE:Rev $2.82 Million, bought HC & Aristotle launched;)

RE:Rev $2.82 Million, bought HC & Aristotle launched;)This is fantastic news and all, but the way it was presented this morning was awful. If Tripp is behind all these ideas, that's great work, but he needs someone to present it, sell it to me, make it exciting and clear what the vision is. The presentation this morning was boggled, with no flow, confusing. He had to have known people were expecting big things after all the radio silence. This presentation had to be a masterpiece to keep that momentum,  actually Q3 and Q2 presentations had more energy. Give that investor confidence, a mid-quarter update to the investors, they want to be appeased, know where their money is going. All the pieces are there, and Tripp has been a huge part of that, but even the best coaches are dismissed when the team has lost confidence. This is a penny stock in the end, with so much potential, but what happened today scares away a lot of hard earned money and it was easily preventable. Is he too busy behind the scenes to put together something digestible to shareholders? Is he wearing too many hats and needs to delegate some work to someone more talented in marketing? What's your opinion on this? 
<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse